AI Verdict
MAX has stronger fundamentals based on our AI analysis.
MAZE vs MAX Fundamental Comparison
| Metric | MAZE | MAX |
|---|---|---|
| Revenue | $0.0 | $1.1B |
| Net Income | $-131.1M | $25.6M |
| Net Margin | N/A | 2.3% |
| ROE | -36.9% | 615.9% |
| ROA | -33.0% | 6.7% |
| Current Ratio | 15.50x | 1.18x |
| Debt/Equity | 0.00x | 36.88x |
| EPS | $-3.05 | $0.39 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MAZE vs MAX: Frequently Asked Questions
Is MAZE or MAX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MAX has stronger fundamentals. MAZE is rated STRONG SELL (92% confidence) while MAX is rated HOLD (45% confidence). This is not investment advice.
How does MAZE compare to MAX fundamentally?
Maze Therapeutics, Inc. has ROE of -36.9% vs MediaAlpha, Inc.'s 615.9%. Net margins are N/A vs 2.3% respectively.
Which stock pays higher dividends, MAZE or MAX?
MAZE has a dividend yield of N/A or no dividend while MAX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MAZE or MAX for long term?
For long-term investing, consider that MAZE has STRONG SELL rating with 92% confidence, while MAX has HOLD rating with 45% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MAZE vs MAX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MAZE vs MAX, the AI consensus favors MAX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.